---
audienceLevel: patient
cancerTypes:
- pancreatic
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Lutetium Lu 177-Dotatate - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/lutetiumlu177-dotatate
version: v1
---

# Lutetium Lu 177-Dotatate - NCI

# Lutetium Lu 177-Dotatate

Placeholder slot

(loo-TEE-shee-um â€¦ DOH-tuh-tayt )

This page contains brief information about lutetium Lu 177-dotatate
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Lutathera

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72d1a024-00b7-418a-b36e-b2cb48f2ab55)

## Use in Cancer

Lutetium Lu 177-dotatate
is approved to treat:

- **[Gastroenteropancreatic neuroendocrine tumors](/Common/PopUps/popDefinition.aspx?id=792398&version=Patient&language=English).** It is used in adults and children aged 12 years and older whose cancer is [somatostatin receptor](/Common/PopUps/popDefinition.aspx?id=792400&version=Patient&language=English) [positive](/Common/PopUps/popDefinition.aspx?id=44710&version=Patient&language=English).

Lutetium Lu 177-dotatate
is also being studied in the treatment of other types of
cancer.

## More About Lutetium Lu 177-Dotatate

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/715523) - Detailed scientific definition and other names for this drug.

## Research Results and Related Resources

[Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine Tumors](https://www.cancer.gov/news-events/cancer-currents-blog/2024/lutathera-neuroendocrine-tumor-initial-treatment)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age](https://www.cancer.gov/news-events/cancer-currents-blog/2020/radiopharmaceuticals-cancer-radiation-therapy)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Lutetium Lu 177 Dotatate](https://www.cancer.gov/research/participate/clinical-trials/intervention/C95020) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
